Sold out

Medicine

ACTRAPID INSULIN 100IU 3ML 5’S (PHILLIPS)

Login to view prices

SKU:

COLDA012

Description

ACTRAPID INSULIN 100IU 3ML 5’S (PHILLIPS) is a short-acting insulin formulation used to manage blood glucose levels in individuals with diabetes mellitus. Manufactured by Novo Nordisk, this insulin is produced using recombinant DNA technology to ensure purity and consistency.

Key Features:

• Rapid Onset: Begins to lower blood glucose levels approximately 30 minutes after subcutaneous injection.
• Duration of Action: Effect lasts for about 7–8 hours, making it suitable for controlling postprandial (after meal) blood sugar spikes. (European Medicines Agency (EMA))
• Composition: Each milliliter contains 100 IU of human insulin, with a total of 500 IU per 5 ml cartridge.
• Administration: Injected subcutaneously, typically into the abdomen, thigh, or upper arm.
• Compatibility: Designed for use with Novo Nordisk insulin delivery systems, such as FlexPen and Penfill devices. (Drugs.com)

Usage Instructions:

• Dosage: Follow the dosage prescribed by your healthcare provider, as it varies based on individual needs and blood glucose monitoring.
• Injection Sites: Rotate injection sites to prevent lipodystrophy (changes in fat tissue).
• Storage: Store unopened cartridges in the refrigerator between 2°C and 8°C. Once in use, the cartridge can be kept at room temperature for up to 28 days. (1mg)

Precautions:

• Hypoglycemia Risk: Monitor for signs of low blood sugar, such as shaking, sweating, or confusion, especially during peak insulin action times.
• Medical Conditions: Inform your doctor if you have liver, kidney, or heart disease, as dosage adjustments may be necessary.
• Pregnancy and Breastfeeding: Consult your healthcare provider before use during pregnancy or while breastfeeding.

Side Effects:

• Common: Injection site reactions (redness, swelling), hypoglycemia.
• Less Common: Lipodystrophy, allergic reactions.
• Rare: Severe allergic reactions; seek immediate medical attention if symptoms occur.

Note: Always consult with a healthcare professional before starting or adjusting insulin therapy.